Cargando…

Severe Malarial Thrombocytopenia: A Risk Factor for Mortality in Papua, Indonesia

BACKGROUND: The significance of thrombocytopenia to the morbidity and mortality of malaria is poorly defined. We compared the platelet counts and clinical correlates of patients with and those without malaria in southern Papua, Indonesia. METHODS: Data were collated on patients presenting to a refer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lampah, Daniel A., Yeo, Tsin W., Malloy, Michael, Kenangalem, Enny, Douglas, Nicholas M., Ronaldo, Donny, Sugiarto, Paulus, Simpson, Julie A., Poespoprodjo, Jeanne Rini, Anstey, Nicholas M., Price, Ric N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2015
Materias:	Major Articles and Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4305266/ https://www.ncbi.nlm.nih.gov/pubmed/25170106 http://dx.doi.org/10.1093/infdis/jiu487

Ejemplares similares

Mortality attributable to Plasmodium vivax malaria: a clinical audit from Papua, Indonesia
por: Douglas, Nicholas M, et al.
Publicado: (2014)

Malaria-related hospitalization during childhood in Papua, Indonesia: A retrospective cohort study
por: Douglas, Nicholas M., et al.
Publicado: (2020)

Coma Associated with Microscopy-Diagnosed Plasmodium vivax: A Prospective Study in Papua, Indonesia
por: Lampah, Daniel A., et al.
Publicado: (2011)

Early and late mortality after malaria in young children in Papua, Indonesia
por: Patriani, Dewi, et al.
Publicado: (2019)

The risk of adverse clinical outcomes following treatment of Plasmodium vivax malaria with and without primaquine in Papua, Indonesia
por: Thriemer, Kamala, et al.
Publicado: (2020)

Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia
por: Setyadi, Agus, et al.
Publicado: (2019)

The risk of morbidity and mortality following recurrent malaria in Papua, Indonesia: a retrospective cohort study
por: Dini, Saber, et al.
Publicado: (2020)

Multidrug-Resistant Plasmodium vivax Associated with Severe and Fatal Malaria: A Prospective Study in Papua, Indonesia
por: Tjitra, Emiliana, et al.
Publicado: (2008)

Major Burden of Severe Anemia from Non-Falciparum Malaria Species in Southern Papua: A Hospital-Based Surveillance Study
por: Douglas, Nicholas M., et al.
Publicado: (2013)

Unsupervised primaquine for the treatment of Plasmodium vivax malaria relapses in southern Papua: A hospital-based cohort study
por: Douglas, Nicholas M., et al.
Publicado: (2017)

High Risk of Plasmodium vivax Malaria Following Splenectomy in Papua, Indonesia
por: Kho, Steven, et al.
Publicado: (2019)

Treatment-seeking behaviour and associated costs for malaria in Papua, Indonesia
por: Karyana, Muhammad, et al.
Publicado: (2016)

Dihydroartemisinin-Piperaquine Treatment of Multidrug Resistant Falciparum and Vivax Malaria in Pregnancy
por: Poespoprodjo, Jeanne Rini, et al.
Publicado: (2014)

Treatment-Seeking Behavior after the Implementation of a Unified Policy of Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Malaria in Papua, Indonesia
por: Devine, Angela, et al.
Publicado: (2018)

Intravenous artesunate plus oral dihydroartemisinin–piperaquine or intravenous quinine plus oral quinine for optimum treatment of severe malaria: lesson learnt from a field hospital in Timika, Papua, Indonesia
por: Sikora, Silvester Alexandro, et al.
Publicado: (2019)

Plasmodium malariae Infection Associated with a High Burden of Anemia: A Hospital-Based Surveillance Study
por: Langford, Siobhan, et al.
Publicado: (2015)

Treatment policy change to dihydroartemisinin–piperaquine contributes to the reduction of adverse maternal and pregnancy outcomes
por: Poespoprodjo, Jeanne Rini, et al.
Publicado: (2015)

Submicroscopic and Asymptomatic Plasmodium Parasitaemia Associated with Significant Risk of Anaemia in Papua, Indonesia
por: Pava, Zuleima, et al.
Publicado: (2016)

Malaria morbidity and mortality following introduction of a universal policy of artemisinin-based treatment for malaria in Papua, Indonesia: A longitudinal surveillance study
por: Kenangalem, Enny, et al.
Publicado: (2019)

Therapeutic Response to Dihydroartemisinin–Piperaquine for P. falciparum and P. vivax Nine Years after Its Introduction in Southern Papua, Indonesia
por: Poespoprodjo, Jeanne Rini, et al.
Publicado: (2018)

Impacts of tuberculosis services strengthening and the COVID-19 pandemic on case detection and treatment outcomes in Mimika District, Papua, Indonesia: 2014–2021
por: Lestari, Trisasi, et al.
Publicado: (2022)

Adherence to 14-day radical cure for Plasmodium vivax malaria in Papua, Indonesia: a mixed-methods study
por: Rahmalia, Annisa, et al.
Publicado: (2023)

Malaria morbidity in Papua Indonesia, an area with multidrug resistant Plasmodium vivax and Plasmodium falciparum
por: Karyana, Muhammad, et al.
Publicado: (2008)

Molecular surveillance over 14 years confirms reduction of Plasmodium vivax and falciparum transmission after implementation of Artemisinin-based combination therapy in Papua, Indonesia
por: Pava, Zuleima, et al.
Publicado: (2020)

Supervised versus unsupervised primaquine radical cure for the treatment of falciparum and vivax malaria in Papua, Indonesia: a cluster-randomised, controlled, open-label superiority trial
por: Poespoprodjo, Jeanne Rini, et al.
Publicado: (2022)

The burden and treatment of HIV in tuberculosis patients in Papua Province, Indonesia: a prospective observational study
por: Pontororing, Gysje J, et al.
Publicado: (2010)

Intermittent screening and treatment for malaria complementary to routine immunisation in the first year of life in Papua, Indonesia: a cluster randomised superiority trial
por: Poespoprodjo, Jeanne Rini, et al.
Publicado: (2022)

Gametocyte Dynamics and the Role of Drugs in Reducing the Transmission Potential of Plasmodium vivax
por: Douglas, Nicholas M., et al.
Publicado: (2013)

Glycocalyx Breakdown Is Associated With Severe Disease and Fatal Outcome in Plasmodium falciparum Malaria
por: Yeo, Tsin W, et al.
Publicado: (2019)

A Randomized Pilot Study of L-Arginine Infusion in Severe Falciparum Malaria: Preliminary Safety, Efficacy and Pharmacokinetics
por: Yeo, Tsin W., et al.
Publicado: (2013)

Impaired Systemic Tetrahydrobiopterin Bioavailability and Increased Dihydrobiopterin in Adult Falciparum Malaria: Association with Disease Severity, Impaired Microvascular Function and Increased Endothelial Activation
por: Yeo, Tsin W., et al.
Publicado: (2015)

Plasmodium vivax infection: a major determinant of severe anaemia in infancy
por: Kenangalem, Enny, et al.
Publicado: (2016)

Genetic micro-epidemiology of malaria in Papua Indonesia: Extensive P. vivax diversity and a distinct subpopulation of asymptomatic P. falciparum infections
por: Pava, Zuleima, et al.
Publicado: (2017)

Increased circulating myeloid-derived suppressor cells in vivax malaria and severe falciparum malaria
por: Leonardo, Leo, et al.
Publicado: (2022)

Tuberculosis Outcomes in Papua, Indonesia: The Relationship with Different Body Mass Index Characteristics between Papuan and Non-Papuan Ethnic Groups
por: Kenangalem, Enny, et al.
Publicado: (2013)

Loss of complement regulatory proteins on uninfected erythrocytes in vivax and falciparum malaria anemia
por: Oyong, Damian A., et al.
Publicado: (2018)

Highly Effective Therapy for Maternal Malaria Associated With a Lower Risk of Vertical Transmission
por: Poespoprodjo, J. R., et al.
Publicado: (2011)

Longitudinal ex vivo and molecular trends of chloroquine and piperaquine activity against Plasmodium falciparum and P. vivax before and after introduction of artemisinin-based combination therapy in Papua, Indonesia
por: Marfurt, Jutta, et al.
Publicado: (2021)

Safety Profile of L-Arginine Infusion in Moderately Severe Falciparum Malaria
por: Yeo, Tsin W., et al.
Publicado: (2008)

The anaemia of Plasmodium vivax malaria
por: Douglas, Nicholas M, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_q7lshleho48kn77aoqvb9t0bhr